Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cyanotech Corp. (NASDAQ: CYAN).

Full DD Report for CYAN

You must become a subscriber to view this report.


Recent News from (NASDAQ: CYAN)

Cyanotech signs asset purchase agreement for Cellana's Kona Demonstration facility
Cyanotech (NASDAQ: CYAN ) announced it has signed an Asset Purchase Agreement with Cellana LLC to acquire a six-acre production and research facility, known as the Kona Demonstration Facility. The acquisition includes all existing equipment and other assets necessary to operate the facilit...
Source: SeekingAlpha
Date: September, 07 2018 15:19
Cyanotech® Corporation Signs Asset Purchase Agreement for Cellana's Kona Demonstration Facility
Cyanotech ® Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, is pleased to announce that it has signed an Asset Purchase Agreement with Cellana LLC to acquire a six-acre production and research facility, known as t...
Source: Business Wire
Date: September, 07 2018 13:00
Cyanotech Corporation (CYAN) CEO Mawae Morton on Q1 2019 Results - Earnings Call Transcript
Cyanotech Corporation (CYAN) Q1 2019 Earnings Conference Call August 14, 2018, 08:00 PM ET Executives Mawae Morton - CEO Jole Deal - CFO Analysts Presentation Operator Mawae Morton Aloha from Kona, Hawaii. Thank you all for joining us today on the earnings call re...
Source: SeekingAlpha
Date: August, 14 2018 22:56
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the first quarter of fiscal year 2019, ended June 30, 2018. First Quarter Fiscal 2019 For the first quarter of fiscal 2...
Source: Business Wire
Date: August, 13 2018 08:00
Cyanotech Corporation (CYAN) CEO Mawae Morton on Q4 2018 Results - Earnings Call Transcript
Cyanotech Corporation (CYAN) Q4 2018 Earnings Conference Call June 20, 2018 05:00 PM ET Executives Mawae Morton - CEO Jole Deal - CFO Presentation Mawae Morton Aloha from Kona, Hawaii. Thank you all for joining us today. We're pleased to report Cyanotech Corporation's fis...
Source: SeekingAlpha
Date: June, 20 2018 22:03
Cyanotech reports Q4 results
Cyanotech (NASDAQ: CYAN ): Q4 EPS of -$0.18 More news on: Cyanotech Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: June, 15 2018 08:02
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2018
— FY2018 Sales Up 6.5%; EPS $0.18 vs. ($0.21) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal year 2018, ended March 31, 201...
Source: Business Wire
Date: June, 15 2018 08:00
Cyanotech: An Opportune Moment To Buy
Bad news shook investor confidence in Cyanotech (CYAN), an algae-centric company known for selling Astaxanthan and Spirulina. Management announced on April 13th, after the market closed, that the company had been forced to undertake an extensive cleaning of some of their ponds on the Kona ...
Source: SeekingAlpha
Date: April, 18 2018 14:08
Midday Gainers / Losers (04/16/2018)
Gainers: OSN +26% . ERI +17% . SHOS +13% . APLS +13% . HEAR +13% . FTD +12% . FSCT +12% . OASM +11% . PMTS +11% . BXC +11% . More news on: Ossen Innovation Co., Ltd., Eldorado Resorts, Inc., Sears Hometown and Outlet Stores, Inc., Stocks on the move, , ...
Source: SeekingAlpha
Date: April, 16 2018 12:40
Wired News - Aimmune Therapeutics' Peanut Allergy Drug AR101 Met Primary Endpoint in Pivotal Phase-3 Clinical Trial
Stock Monitor: Cyanotech Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 22, 2018 / Active-Investors.com has just released a free research report on Aimmune Therapeutics, Inc. (NASDAQ: AIMT ). If you want access to this report all you need to do is sign up now by clicking ...
Source: ACCESSWIRE IA
Date: February, 22 2018 07:40

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-073.753.653.753.6257,929
2018-12-063.573.573.573.561,952
2018-12-053.703.703.703.70636
2018-12-043.703.703.703.70213
2018-12-033.613.653.653.61779

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-071511513.0435Cover
2018-12-0622020.9901Cover
2018-12-041511.9608Cover
2018-11-3020052038.4615Short
2018-11-2955100.0000Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CYAN.


About Cyanotech Corp. (NASDAQ: CYAN)

Logo for Cyanotech Corp. (NASDAQ: CYAN)

Not available

 

Contact Information

 

 

Current Management

  • Gerald R. Cysewski / President, CEO
  • William R. Maris / CFO

Current Share Structure

  • Market Cap: $23,298,565 - 05/15/2018
  • Issue and Outstanding: 5,752,732 - 02/06/2018

 


Recent Filings from (NASDAQ: CYAN)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Type: SC 13DFiling Source: edgar
Filing Date: February, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 06 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 25 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: November, 06 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 06 2017
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: October, 31 2017
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: October, 31 2017
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: October, 31 2017

 

 


Daily Technical Chart for (NASDAQ: CYAN)

Daily Technical Chart for (NASDAQ: CYAN)


Stay tuned for daily updates and more on (NASDAQ: CYAN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CYAN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CYAN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CYAN and does not buy, sell, or trade any shares of CYAN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/